Member Info for Seawolf

Even with the bonus of Atome, most people will have significant losses. Personally I don’t like consolidations and don’t feel that doing this will enable me to recoup that loss. Sell or hold, that is the choice! Does anyone think that the future will be better by holding? Hoping that Paraguay may offer a chance, but would prefer that to happen before any consolidation.

Hbd, if 1801 gets through phase 1 trials, I don’t see funding for 1802 being a problem, there will be lots of people willing to support it.
I would be happy to partake in a fundraiser to achieve that goal.

Gents, interesting to see the range of expectation for various assets. I’m sure the BOD have a figure in mind regarding the worth of each molecule and the company as a whole. They obviously won’t share that with shareholders but make no mistake they do have a price, it just needs an interested party to find out what that might be.
GLA

You may well put aside £115 but the new cap is three times that! This really is a serious situation. Elderly people will suffer the most with low incomes and soaring costs. Residential homes for the elderly will close due to rising costs for heating etc…..

Thanks HBD, hopefully in their Q3 update as Q2 already contains Momo, they aren't wasting any time and seem to be on the ball. Time is money to a giant like GSK.

Oh yes I hope so, either CTA granted or GSK updating their pipeline to include a new molecule (ex SRA 737) now GSK........
We know both are coming soon, either later this month or during September. Hold on to those shares peeps, dont get caught out by stop losses, and set your sell targets high.
GLA

By the end of September, I'm looking forward to those, hoping President has turned a corner at last!

There was an article in the guardian today outlining advances in immunotherapy and combination therapy. It seems that this has been ongoing for a few years with significant success.
My fear is that delays caused by Sierra has put us behind in the race to effectively treat patients with many forms of cancer, have we missed the boat with SRA737?
I hope not , hopefully GSK will tell us soon.

Just remember folks, a deal can happen relatively quickly, take the Sierra deal as an example.
GLA

Lazarus, I thought from earlier RNS’s and presentations that 1802 would be hot on the heels of 1801. For me that would be 3 to six months behind due to their similarities. I now suspect that cash is the constraint on this, from the presentation yesterday. There is nothing wrong with 1802 but it would have been nice to see this going into clinic next year. It will but not as soon as I thought!

HBD, I don’t see why the CRO can’t be named, although all will become clear once it gets underway.

Fearg, if GSK take 737 further we will be due an influx of cash that will resolve any finance issues, and hopefully within 12 months.
Still looking very positive on all fronts. I am just a little disappointed that 1802 is not quite as far along as I had hoped.

I don’t know what is wrong but Ppc is worth more than the current SP, but the market clearly has a different view. I can’t get my head around what it is, is it the company or PL?
Something needs to change as clearly it’s not working.

Me too, one about each molecule and one on funding going forward!

Has anyone submitted questions via investor meet?

For each step along the journey, the value increases significantly. The RNS today is very good news and the fact that we have 3 very good products which will tackle a range of illnesses and conditions is truly staggering.
This little company has the potential to be a blockbuster, hold on very tight folks.

GLA

Doc,
No link visit the wall at site for free and lookup ppc, it gives a good overview.

Did a summary of PPC last week which is worth a read, it kind of supports the woeful situation we are in, and the reasons why!

Just for the record, this is not another missed deadline. At no point has Sareum tied themselves to a 1st of July deadline for anything. LTH’s know that when the time is ready the BOD will announce what information they can. Watch and wait, buy or sell, the choice is upto each individual. I’m waiting and holding GLA.

Oh yes, there are hundreds of them, not! After the many millions previously spent in Paraguay, why on earth would you drill an exploration well with only a 17 % chance of success, this alone baffles me, or am I missing something?
An increase in profit due to the price of oil will of course be welcomed this financial year unless PL blows it 9n something trivial. Atome is still a way off in terms of generating cash, so no upside there in the short to medium term. Oh well, what’s another year?